Fig. 1From: Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension studyPatient disposition. ATS, All Treated Set; ATS-OLE, All Treated Set of the open-label extension; OLE, open-label extension; rhPTX-2, recombinant human pentraxin-2; SAF-OLE, Safety Analysis Set of the open-label extensionBack to article page